- Home
- IBRX vs NSA Comparison
IBRX vs NSA Comparison
Compare IBRX & NSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBRX | NSA |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | IBRX | NSA |
|---|---|---|
| Price | $2.05 | $27.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | $9.71 | ★ $33.22 |
| AVG Volume (30 Days) | ★ 13.6M | 1.1M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 8.08% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | $82,555,000.00 | ★ $741,511,000.00 |
| Revenue This Year | $667.18 | N/A |
| Revenue Next Year | $93.03 | $1.11 |
| P/E Ratio | ★ N/A | $46.36 |
| Revenue Growth | ★ 1025.95 | N/A |
| 52 Week Low | $1.83 | $27.47 |
| 52 Week High | $4.27 | $40.62 |
Technical Indicators
Market Signals| Indicator | IBRX | NSA |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 39.32 |
| Support Level | $1.95 | $27.47 |
| Resistance Level | $2.29 | $28.54 |
| Average True Range (ATR) | 0.12 | 0.48 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 19.09 | 18.59 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.